Macrocast

Going for the green diagonal

Key points

  • We look at an understated aspect of the US administration’s “green conversion”, the role of the federal regulatory agencies, in the context of the US attempt to assert global leadership in the fight against climate change.

The US administration’s green investment plan is spectacular and understandably grabs global attention, but we think a more discrete thread of US activism in the fight against climate change deserves some attention: federal regulatory agencies are stepping up their efforts in embracing green issues. The legal ramifications of their approach are often complex, but it can be an effective accelerator of the ecological transition in the US.
The EPA is reconsidering a petition to include CO2 emissions in the scope of the National Ambient Air Quality Standards framework, which would force all 50 states to design a carbon strategy, with penalties in case of non-attainment, without the need of congressional action. In practice, it could be a cumbersome approach and may not be the simplest way to advance the fight against climate change in the US, but it may convince moderate Democratic and Republican Senators to reach a compromise with the White House on the green investment plan. At the same time, the SEC is stepping up its efforts in the field of green finance regulation, an area in which the US has traditionally been a laggard.
Joe Biden has convened a meeting of 40 heads of government this week to “build momentum” ahead of COP26. The US clearly wants to assert some leadership on the green transition. They probably see China as their main competitor on this, as on many other issues, after Beijing’s unexpected pledge last year to reach “net zero” by 2060. However, on the regulatory aspects, and especially on green finance, the real competitor may well be the European Union. The EU is ahead, but the US clearly want to catch up fast. An issue, in terms of collective welfare, is whether some harmonization towards a common benchmark will be possible to build.
Also, this week we look at the progress in the European vaccination programme, exploring some of the supply constraints ahead. We continue to think that ensuring collective immunity at the beginning of Q3 will be difficult and provide some quantification of the “tourism crash” of last summer.

This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.

Neither MSCI nor any other party involved in or related to compiling, computing or creating the MSCI data makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in or related to compiling, computing or creating the data have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. No further distribution or dissemination of the MSCI data is permitted without MSCI’s express written consent.

This document has been edited by AXA INVESTMENT MANAGERS SA, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 393 051 826. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.

In the UK, this document is intended exclusively for professional investors, as defined in Annex II to the Markets in Financial Instruments Directive 2014/65/EU (“MiFID”). Circulation must be restricted accordingly. 

© AXA Investment Managers 2021. All rights reserved